OBJECTIVE: Mitochondrial dysfunction may play a role in the pathogenesis of sepsis-induced organ dysfunction. Respiratory-chain deficiencies that occur in sepsis, however, have never been shown to cause organ failure or to be reversible. Cytochrome oxidase uses electrons donated by its substrate, cytochrome c, to reduce oxygen to H2O. In the septic heart, cytochrome oxidase is competitively inhibited. We hypothesized that cytochrome oxidase inhibition coupled with reduced substrate availability is a reversible cause of sepsis-associated myocardial depression. DESIGN: Prospective observational study aimed to overcome myocardial cytochrome oxidase inhibition with excess cytochrome c and improve cardiac function. SETTING: University hospital-based laboratory. SUBJECTS: Seventy-five C57Bl6 male mice. INTERVENTIONS: Mice underwent cecal ligation and double puncture, sham operation, or no operation. Exogenous cytochrome c or an equal volume of saline was intravenously injected at the 24-hr time point. All animals were evaluated 30 mins after injection. MEASUREMENTS AND MAIN RESULTS: Exogenous cytochrome c readily repleted cardiac mitochondria with supranormal levels of substrate (>1.6 times baseline), restored heme c content, and increased cytochrome oxidase kinetic activity. This increased left ventricular pressure and increased pressure development during isovolumic contraction (dP/dtmax) and relaxation (dP/dtmin) by >45% compared with saline injection. CONCLUSION: Impaired oxidative phosphorylation is a cause of sepsis-associated myocardial depression, and mitochondrial resuscitation with exogenous cytochrome c overcomes cytochrome oxidase inhibition and improves cardiac function.
OBJECTIVE:Mitochondrial dysfunction may play a role in the pathogenesis of sepsis-induced organ dysfunction. Respiratory-chain deficiencies that occur in sepsis, however, have never been shown to cause organ failure or to be reversible. Cytochrome oxidase uses electrons donated by its substrate, cytochrome c, to reduce oxygen to H2O. In the septic heart, cytochrome oxidase is competitively inhibited. We hypothesized that cytochrome oxidase inhibition coupled with reduced substrate availability is a reversible cause of sepsis-associated myocardial depression. DESIGN: Prospective observational study aimed to overcome myocardial cytochrome oxidase inhibition with excess cytochrome c and improve cardiac function. SETTING: University hospital-based laboratory. SUBJECTS: Seventy-five C57Bl6 male mice. INTERVENTIONS:Mice underwent cecal ligation and double puncture, sham operation, or no operation. Exogenous cytochrome c or an equal volume of saline was intravenously injected at the 24-hr time point. All animals were evaluated 30 mins after injection. MEASUREMENTS AND MAIN RESULTS: Exogenous cytochrome c readily repleted cardiac mitochondria with supranormal levels of substrate (>1.6 times baseline), restored heme c content, and increased cytochrome oxidase kinetic activity. This increased left ventricular pressure and increased pressure development during isovolumic contraction (dP/dtmax) and relaxation (dP/dtmin) by >45% compared with saline injection. CONCLUSION: Impaired oxidative phosphorylation is a cause of sepsis-associated myocardial depression, and mitochondrial resuscitation with exogenous cytochrome c overcomes cytochrome oxidase inhibition and improves cardiac function.
Authors: Michael A Puskarich; Jeffrey A Kline; John A Watts; Kristin Shirey; Jonathan Hosler; Alan E Jones Journal: J Crit Care Date: 2015-10-26 Impact factor: 3.425
Authors: Nishkantha Arulkumaran; Clifford S Deutschman; Michael R Pinsky; Brian Zuckerbraun; Paul T Schumacker; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum Journal: Shock Date: 2016-03 Impact factor: 3.454
Authors: Hao Liu; Syana M Sarnaik; Mioara D Manole; Yaming Chen; Sunita N Shinde; Wenjin Li; Marie Rose; Henry Alexander; Jie Chen; Robert S B Clark; Steven H Graham; Robert W Hickey Journal: Resuscitation Date: 2012-05-01 Impact factor: 5.262
Authors: Maik Hüttemann; Petr Pecina; Matthew Rainbolt; Thomas H Sanderson; Valerian E Kagan; Lobelia Samavati; Jeffrey W Doan; Icksoo Lee Journal: Mitochondrion Date: 2011-02-04 Impact factor: 4.160